Staar Surgical Co (STAA)
42.70
+0.08
(+0.19%)
USD |
NASDAQ |
May 17, 16:00
42.72
+0.02
(+0.05%)
After-Hours: 20:00
Staar Surgical Cash from Investing (Quarterly): 16.19M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 16.19M |
December 31, 2023 | 22.40M |
September 30, 2023 | 31.84M |
June 30, 2023 | 10.17M |
March 31, 2023 | 9.933M |
December 31, 2022 | -46.72M |
September 30, 2022 | -101.85M |
June 30, 2022 | -5.271M |
March 31, 2022 | -2.539M |
December 31, 2021 | -4.689M |
September 30, 2021 | -3.273M |
June 30, 2021 | -3.524M |
March 31, 2021 | -2.159M |
December 31, 2020 | -2.145M |
September 30, 2020 | -2.049M |
June 30, 2020 | -2.025M |
March 31, 2020 | -2.185M |
December 31, 2019 | -2.979M |
September 30, 2019 | -2.568M |
June 30, 2019 | -2.398M |
March 31, 2019 | -2.233M |
December 31, 2018 | -0.524M |
September 30, 2018 | -0.452M |
June 30, 2018 | -0.304M |
March 31, 2018 | -0.965M |
Date | Value |
---|---|
December 31, 2017 | -0.077M |
September 30, 2017 | -0.345M |
June 30, 2017 | -0.378M |
March 31, 2017 | -0.246M |
December 31, 2016 | -0.496M |
September 30, 2016 | -0.718M |
June 30, 2016 | -0.985M |
March 31, 2016 | -1.006M |
December 31, 2015 | -0.762M |
September 30, 2015 | -0.582M |
June 30, 2015 | -0.373M |
March 31, 2015 | -0.326M |
December 31, 2014 | 0.406M |
September 30, 2014 | -0.248M |
June 30, 2014 | -0.787M |
March 31, 2014 | -1.414M |
December 31, 2013 | -0.464M |
September 30, 2013 | -0.967M |
June 30, 2013 | -0.799M |
March 31, 2013 | -1.218M |
December 31, 2012 | -1.114M |
September 30, 2012 | -0.328M |
June 30, 2012 | -0.546M |
March 31, 2012 | -0.158M |
December 31, 2011 | -0.241M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-101.85M
Minimum
Sep 2022
31.84M
Maximum
Sep 2023
-4.792M
Average
-2.292M
Median
Cash from Investing (Quarterly) Benchmarks
Anika Therapeutics Inc | -1.808M |
The Cooper Companies Inc | -324.10M |
OrthoPediatrics Corp | -3.679M |
NexGel Inc | -0.273M |
Innovative Eyewear Inc | 2.010M |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | 21.68M |
Cash from Financing (Quarterly) | 4.056M |
Free Cash Flow | 20.88M |
Free Cash Flow Per Share (Quarterly) | 0.3369 |
Free Cash Flow to Equity (Quarterly) | 16.48M |
Free Cash Flow to Firm (Quarterly) | 16.48M |
Free Cash Flow Yield | 0.99% |